Goelzer Investment Management Inc. Has $8.36 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Goelzer Investment Management Inc. boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 10.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 16,532 shares of the healthcare conglomerate’s stock after buying an additional 1,535 shares during the quarter. Goelzer Investment Management Inc.’s holdings in UnitedHealth Group were worth $8,363,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the business. Kathleen S. Wright Associates Inc. acquired a new stake in shares of UnitedHealth Group during the 3rd quarter worth approximately $27,000. Global Wealth Strategies & Associates grew its position in UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 32 shares during the period. West Financial Advisors LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter worth about $32,000. Quarry LP increased its holdings in shares of UnitedHealth Group by 132.1% during the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 37 shares in the last quarter. Finally, RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group during the 3rd quarter worth approximately $37,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have recently weighed in on UNH shares. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday. TD Cowen raised their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. Royal Bank of Canada lowered their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Barclays decreased their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and an average target price of $627.74.

UnitedHealth Group Price Performance

UNH stock opened at $532.26 on Friday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market cap of $489.83 billion, a PE ratio of 34.34, a price-to-earnings-growth ratio of 1.41 and a beta of 0.62. The stock has a 50-day moving average price of $542.24 and a two-hundred day moving average price of $563.54. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $5.83 EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.74 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.58%. UnitedHealth Group’s payout ratio is presently 54.19%.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction dated Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.